Security Snapshot

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) Institutional Ownership

CUSIP: 413197104

13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

321

Shares (Excl. Options)

49,870,766

Price

$37.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
HRMY on Nasdaq
Shares outstanding
57,644,670
Price per share
$28.01
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
49,870,766
Total reported value
$1,865,507,186
% of total 13F portfolios
0%
Share change
+2,437,338
Value change
+$94,115,093
Number of holders
321
Price from insider filings
$28.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • HRMY - Harmony Biosciences Holdings, Inc. - Common Stock is tracked under CUSIP 413197104.
  • 321 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 321 to 20 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,865,507,186 to $70,759,389.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 321 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Marshman Fund Trust II 11% $178,084,462 6,051,120 Marshman Fund Trust II 31 Dec 2024
BlackRock, Inc. 10% -18% $169,781,023 -$35,290,072 5,768,978 -17% BlackRock, Inc. 31 Mar 2025
FMR LLC 5.4% -19% $116,481,431 -$27,472,267 3,112,812 -19% FMR LLC 31 Dec 2025

As of 31 Dec 2025, 321 institutional investors reported holding 49,870,766 shares of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY). This represents 87% of the company’s total 57,644,670 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) together control 60% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 7,088,688 +2.3% 0% $265,258,704
VANGUARD GROUP INC 8.4% 4,813,357 -5.6% 0% $180,115,819
FMR LLC 5.4% 3,112,812 -19% 0.01% $116,481,430
AMERICAN CENTURY COMPANIES INC 3.2% 1,841,672 +10% 0.03% $68,915,366
DIMENSIONAL FUND ADVISORS LP 3.2% 1,830,726 +8.2% 0.01% $68,506,807
STATE STREET CORP 2.9% 1,661,850 +0.5% 0% $62,186,427
LSV ASSET MANAGEMENT 2.9% 1,657,093 +3.9% 0.14% $62,008,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2.6% 1,491,605 +15% 0.03% $55,815,859
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,270,586 +0.98% 0% $47,551,305
RENAISSANCE TECHNOLOGIES LLC 1.9% 1,070,471 -5.9% 0.06% $40,057,025
SG Americas Securities, LLC 1.7% 961,667 +4102% 0.05% $35,986,000
MORGAN STANLEY 1.4% 817,506 -3.6% 0% $30,591,084
AQR CAPITAL MANAGEMENT LLC 1.4% 813,889 +129% 0.02% $30,455,726
Boston Partners 1.2% 708,943 -6% 0.03% $26,367,837
GOLDMAN SACHS GROUP INC 0.99% 569,362 -12% 0% $21,305,526
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.94% 541,281 -5.1% 0.01% $20,254,735
BNP PARIBAS FINANCIAL MARKETS 0.91% 525,145 0% 0.01% $19,650,926
NOMURA HOLDINGS INC 0.88% 510,024 +17% 0.14% $19,085,098
ARMISTICE CAPITAL, LLC 0.87% 500,000 0.46% $18,710,000
venBio Partners LLC 0.85% 489,194 0% 8.5% $18,305,639
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.8% 459,134 +73% 0.02% $17,180,794
Invesco Ltd. 0.78% 450,805 +12% 0% $16,869,123
CITADEL ADVISORS LLC 0.73% 420,410 +518% 0.01% $15,731,743
NORTHERN TRUST CORP 0.73% 418,938 -3.2% 0% $15,676,660
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.73% 417,955 -8.4% 0% $15,639,876

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,526,311 $70,759,389 +$29,620,095 $28.01 20
2025 Q4 49,870,766 $1,865,507,186 +$94,115,093 $37.42 321
2025 Q3 47,339,126 $1,304,886,690 -$112,498,749 $27.56 292
2025 Q2 51,269,247 $1,620,478,469 +$22,306,889 $31.60 276
2025 Q1 50,193,424 $1,664,235,088 -$100,697,267 $33.19 267
2024 Q4 52,708,406 $1,813,638,877 +$62,320,767 $34.41 244
2024 Q3 50,136,635 $2,005,018,440 +$11,121,046 $40.00 231
2024 Q2 50,163,988 $1,513,604,428 +$34,652,893 $30.17 218
2024 Q1 48,982,561 $1,644,752,000 +$41,053,934 $33.58 206
2023 Q4 47,832,583 $1,544,993,160 -$51,074,763 $32.30 219
2023 Q3 49,527,453 $1,623,105,557 -$85,461,798 $32.77 203
2023 Q2 51,951,129 $1,828,229,880 +$28,751,282 $35.19 207
2023 Q1 51,270,566 $1,674,006,219 -$29,571,258 $32.65 213
2022 Q4 51,015,535 $2,810,596,096 +$34,893,529 $55.10 238
2022 Q3 50,461,165 $2,237,024,113 +$91,703,030 $44.29 195
2022 Q2 47,874,920 $2,335,182,718 +$99,684,851 $48.77 173
2022 Q1 45,933,803 $2,235,023,234 +$79,981,090 $48.65 168
2021 Q4 44,541,354 $1,899,444,678 +$107,131,256 $42.64 138
2021 Q3 30,932,269 $1,185,850,908 +$116,456,188 $38.33 99
2021 Q2 27,994,218 $790,282,400 -$7,611,822 $28.23 79
2021 Q1 27,468,517 $907,561,000 -$18,485,709 $33.04 55
2020 Q4 27,956,363 $998,030,405 -$18,654,367 $36.15 59
2020 Q3 28,549,056 $940,508,000 +$940,508,000 $33.90 44